Renal cell carcinoma

• Study of BGB-A425 and LBL-007 in Combination With Tislelizumab in Advanced Solid Tumors Ended
  2022-500694-14-00 7 2023-06-02 "Head and Neck Squamous Cell Cancer"
• Study to Compare Tivozanib in Combination with Nivolumab to Tivozanib Monotherapy in Subjects with Renal Cell Carcinoma Ended
  2024-514570-43-00 5 2022-01-24
• A Study to Evaluate the Efficacy and Safety of Atezolizumab Given in Combination with Cabozantinib Versus Cabozantinib Alone in Patients wit … Ended
  2024-517785-42-00 5 2020-10-08 "Renal cell carcinoma (RCC)"
• Open-Label Study of Cabozantinib as 2nd Line Treatment in Subjects with Unresectable, Locally Advanced or Metastatic Renal Cell Carcinoma wi … Ended
  2024-514479-16-00 4 2019-10-28 "Unresectable, Locally Advanced or Metastatic Renal Cell Carc"
• A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selecte … Ended
  2024-513915-28-00 3 2019-06-14 "Bladder cancer, Cholangiocarcinoma, Colorectal Cancer, Epith"
• Study of subcutaneous nivolumab monotherapy with or without Recombinant Human Hyaluronidase PH20 (rHuPH20) Ended
  2023-503554-12-00 9 2019-01-09 "lung cancer; kidney cancer; melanoma; liver cancer; colorect"
• Safety Study of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors Ended
  2023-508067-70-00 9 2015-04-15 "Neoplasms by site"

Showing 25–31 of 31 trials